Zahra Pournasiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zahra Pournasiri has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Abbas Madani
Department of Pediatric Nephrology, Children’s Medical Center, Pediatric Chronic Kidney Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
4 shared publications- Abdollah Karimi
Pediatric Infections Research Center, Research Institute for Children's Health Shahid Beheshti University of Medical Sciences Tehran Iran
3 shared publications - Amitis Ramezani
Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran
3 shared publications - Alireza Fahimzad
Pediatric Infectious Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications - Banafshe Dormanesh2 shared publications
- Delaram Doroud
Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 2 May 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (6) , 103242
Baseline epidemiology study of nasopharyngeal carriage and serotypes of Streptococcus pneumoniae in children aged 6–59 months prior to the introduction of pneumococcal conjugate vaccine in Iran
- 2 May 2026
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 19 (6) , 103242
Open AccessBaseline epidemiology study of nasopharyngeal carriage and serotypes of Streptococcus pneumoniae in children aged 6–59 months prior to the introduction of pneumococcal conjugate vaccine in Iran
- 13 November 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (3) , 747-753
Hematuria as a diagnostic marker in pediatric nephrolithiasis without acute obstruction or infection
Background The prevalence of pediatric nephrolithiasis has been rising globally, with hematuria being one of its most frequent diagnostic markers. However, the relationship between stone characteristics and the presence or severity of hematuria in children remains unclear. This study aimed to assess this association in a pediatric population. Methods This observational study included children aged one month to 18 years diagnosed with nephrolithiasis or nephrocalcinosis. Exclusion criteria included patients with systemic diseases, active urinary tract infections, genitourinary anomalies, familial hematuria, recent trauma or fever, urinary tract tumors, or recent episodes of kidney colic. Data on demographics, stones characteristics, urinalysis, and metabolic parameters were analyzed using SPSS v25. Associations with hematuria were assessed using Chi-square and Kruskal–Wallis tests (p < 0.05 significant). Results A total of 260 patients (mean age 5.03 ± 4.57 years; 54.6% male) were included. Hematuria was observed in 40% of cases. Stones located in the ureters and bladder were significantly associated with hematuria (p < 0.05), while lower calyceal stones were linked to lower rates. No significant association was found between stone size or number and hematuria severity. Conclusions Over half of the pediatric patients with nephrolithiasis lacked hematuria, highlighting its limited role as a diagnostic marker. This finding emphasizes the shortcomings of relying solely on urinalysis and supports the need for imaging in the diagnostic work-up of children with suspected nephrolithiasis. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 13 November 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (3) , 747-753
Hematuria as a diagnostic marker in pediatric nephrolithiasis without acute obstruction or infection
Background The prevalence of pediatric nephrolithiasis has been rising globally, with hematuria being one of its most frequent diagnostic markers. However, the relationship between stone characteristics and the presence or severity of hematuria in children remains unclear. This study aimed to assess this association in a pediatric population. Methods This observational study included children aged one month to 18 years diagnosed with nephrolithiasis or nephrocalcinosis. Exclusion criteria included patients with systemic diseases, active urinary tract infections, genitourinary anomalies, familial hematuria, recent trauma or fever, urinary tract tumors, or recent episodes of kidney colic. Data on demographics, stones characteristics, urinalysis, and metabolic parameters were analyzed using SPSS v25. Associations with hematuria were assessed using Chi-square and Kruskal–Wallis tests (p < 0.05 significant). Results A total of 260 patients (mean age 5.03 ± 4.57 years; 54.6% male) were included. Hematuria was observed in 40% of cases. Stones located in the ureters and bladder were significantly associated with hematuria (p < 0.05), while lower calyceal stones were linked to lower rates. No significant association was found between stone size or number and hematuria severity. Conclusions Over half of the pediatric patients with nephrolithiasis lacked hematuria, highlighting its limited role as a diagnostic marker. This finding emphasizes the shortcomings of relying solely on urinalysis and supports the need for imaging in the diagnostic work-up of children with suspected nephrolithiasis. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
Nasopharyngeal Carriage, Serotype Distribution, and Antimicrobial Susceptibility of Streptococcus pneumoniae Among PCV13-Vaccinated and -Unvaccinated Children in Iran
Background and Aim: Pneumococcal pneumonia is a major cause of death globally, emphasizing the importance of vaccination, especially in low- and middle-income countries. In Iran, the 13-valent pneumococcal conjugate vaccine (PCV13) is available exclusively through private healthcare systems, resulting in a lack of studies on the prevalence of Streptococcus pneumoniae (S. pneumoniae) serotypes among vaccinated children. This research aimed to explore and compare the prevalence of nasopharyngeal pneumococcal carriage, serotype distribution, and antibiotic resistance patterns in healthy PCV13-vaccinated and -unvaccinated children. Methods: From August 2023 to November 2024, a multi-center, cross-sectional observational study was conducted in Tehran, Iran. This study included 204 nasopharyngeal samples collected from children aged from 18 to 59 months, involving both cases of children vaccinated with PCV13 and unvaccinated populations. S. pneumoniae was identified through a combination of culture methods and biochemical tests, confirmed by real-time PCR. Serotyping was achieved using cpsB sequencing, and the minimum inhibitory concentration method was employed to assess antibiotic resistance. Results: This study revealed similar S. pneumoniae carriage rates between PCV13-vaccinated and -unvaccinated Iranian children (20.6% vs. 21.6%). Serotypes 23F and 19F were prevalent in unvaccinated children, while 15B/15C was more prevalent in PCV13-vaccinated children. The included S. pneumoniae serotypes in PCV13 were detected more in the unvaccinated group. PCV13-vaccinated children exhibited no penicillin-resistant pneumococcal isolates, although four isolates were non-susceptible in unvaccinated children. Both groups showed substantial resistance to erythromycin and SXT. Previous respiratory infections, daycare attendance, residence in Tehran, and a history of antibiotic consumption increased the risk of pneumococcal carriage. Conclusions: PCV13 vaccination influences pneumococcal serotype distribution and antimicrobial susceptibility, although there was no significant difference regarding carriage rates between vaccinated and unvaccinated groups. These findings highlight the critical importance of vaccination in reducing invasive serotypes and antimicrobial resistance in children under five years old, emphasizing the importance of national PCV vaccination programs alongside continuous serotype surveillance.
Open AccessNasopharyngeal Carriage, Serotype Distribution, and Antimicrobial Susceptibility of Streptococcus pneumoniae Among PCV13-Vaccinated and -Unvaccinated Children in Iran
Background and Aim: Pneumococcal pneumonia is a major cause of death globally, emphasizing the importance of vaccination, especially in low- and middle-income countries. In Iran, the 13-valent pneumococcal conjugate vaccine (PCV13) is available exclusively through private healthcare systems, resulting in a lack of studies on the prevalence of Streptococcus pneumoniae (S. pneumoniae) serotypes among vaccinated children. This research aimed to explore and compare the prevalence of nasopharyngeal pneumococcal carriage, serotype distribution, and antibiotic resistance patterns in healthy PCV13-vaccinated and -unvaccinated children. Methods: From August 2023 to November 2024, a multi-center, cross-sectional observational study was conducted in Tehran, Iran. This study included 204 nasopharyngeal samples collected from children aged from 18 to 59 months, involving both cases of children vaccinated with PCV13 and unvaccinated populations. S. pneumoniae was identified through a combination of culture methods and biochemical tests, confirmed by real-time PCR. Serotyping was achieved using cpsB sequencing, and the minimum inhibitory concentration method was employed to assess antibiotic resistance. Results: This study revealed similar S. pneumoniae carriage rates between PCV13-vaccinated and -unvaccinated Iranian children (20.6% vs. 21.6%). Serotypes 23F and 19F were prevalent in unvaccinated children, while 15B/15C was more prevalent in PCV13-vaccinated children. The included S. pneumoniae serotypes in PCV13 were detected more in the unvaccinated group. PCV13-vaccinated children exhibited no penicillin-resistant pneumococcal isolates, although four isolates were non-susceptible in unvaccinated children. Both groups showed substantial resistance to erythromycin and SXT. Previous respiratory infections, daycare attendance, residence in Tehran, and a history of antibiotic consumption increased the risk of pneumococcal carriage. Conclusions: PCV13 vaccination influences pneumococcal serotype distribution and antimicrobial susceptibility, although there was no significant difference regarding carriage rates between vaccinated and unvaccinated groups. These findings highlight the critical importance of vaccination in reducing invasive serotypes and antimicrobial resistance in children under five years old, emphasizing the importance of national PCV vaccination programs alongside continuous serotype surveillance.
- 25 February 2025
- Published by National Academy of Sciences of Tajikistan
- Vol. 19 (01) , 8-11
The Scent of the Muliyan River (Booye Jooye Muliyan): Report of an Educational Trip
In October 2024, an Iranian educational nephrology team visited Tajikistan to participate in a continuous medical education (CME) course. This report represents the results of their trip from their perspective.
- 25 February 2025
- Published by National Academy of Sciences of Tajikistan
- Vol. 19 (01) , 8-11
The Scent of the Muliyan River (Booye Jooye Muliyan): Report of an Educational Trip
In October 2024, an Iranian educational nephrology team visited Tajikistan to participate in a continuous medical education (CME) course. This report represents the results of their trip from their perspective.
- Open Access
- 1 October 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 14 (1) , e38344
Prevalence of urinary metabolic disorders and risk factors of kidney stones in Iranian children
Introduction: Nephrolithiasis and urolithiasis, characterized by the formation of calculi in the kidney and lower urinary tract, respectively, pose a significant health concern for millions of children worldwide, particularly in developing countries. Objectives: This research aims to explore the prevalence of abnormal concentrations of urinary solutes as potential risk factors for kidney stones in Iranian children under the age of 14 years. Patients and Methods: A cross-sectional investigation spanning from January 2021 to January 2022 targeted children diagnosed with nephrolithiasis or urolithiasis through renal sonography, who were subsequently referred to the nephrology outpatient department of our hospital or our private pediatric nephrology office. Laboratory assessments encompassed urine calcium, oxalate, citrate, uric acid, creatinine, and urine cystine. Demographic attributes, stone composition (when available), and urinary metabolic disorders were scrutinized. Data analysis involved SPSS version 24, utilizing descriptive statistics such as mean, standard deviation, and frequency, categorized by variable type. Chi-square tests were employed for statistical analysis, with a significance threshold set at P<0.05. Results: The study encompassed 486 children, with a mean age of 55.58 months and a male majority of 50.8%. Among those with kidney stones, 77.2% exhibited unilateral stones, while 22.8% presented with bilateral stones. Predominant urinary metabolic disorders included hypercalciuria (30.2%), hyperuricosuria (22.6%), and hyperoxaluria (20.6%). Notably, 25.7% of the children manifested a combination of multiple metabolic disorders. Significant variations in the prevalence of hyperuricosuria were observed across different age groups. Boys exhibited higher incidences of hypercalcemia and metabolic abnormalities compared to girls, though no statistically significant differences were noted in other disorders. Conclusion: In summary, our findings indicate the presence of abnormal urinary metabolic risk factors in over half of children diagnosed with kidney stones. Hypercalciuria was the more frequent risk factor following hyperuricosuria and hyperoxaluria, cystinuria with prevalence of 30.2%, 22.6%, 20.6%, and (2.1%) respectively.
- 1 October 2024
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 14 (1) , e38344
Open AccessPrevalence of urinary metabolic disorders and risk factors of kidney stones in Iranian children
Introduction: Nephrolithiasis and urolithiasis, characterized by the formation of calculi in the kidney and lower urinary tract, respectively, pose a significant health concern for millions of children worldwide, particularly in developing countries. Objectives: This research aims to explore the prevalence of abnormal concentrations of urinary solutes as potential risk factors for kidney stones in Iranian children under the age of 14 years. Patients and Methods: A cross-sectional investigation spanning from January 2021 to January 2022 targeted children diagnosed with nephrolithiasis or urolithiasis through renal sonography, who were subsequently referred to the nephrology outpatient department of our hospital or our private pediatric nephrology office. Laboratory assessments encompassed urine calcium, oxalate, citrate, uric acid, creatinine, and urine cystine. Demographic attributes, stone composition (when available), and urinary metabolic disorders were scrutinized. Data analysis involved SPSS version 24, utilizing descriptive statistics such as mean, standard deviation, and frequency, categorized by variable type. Chi-square tests were employed for statistical analysis, with a significance threshold set at P<0.05. Results: The study encompassed 486 children, with a mean age of 55.58 months and a male majority of 50.8%. Among those with kidney stones, 77.2% exhibited unilateral stones, while 22.8% presented with bilateral stones. Predominant urinary metabolic disorders included hypercalciuria (30.2%), hyperuricosuria (22.6%), and hyperoxaluria (20.6%). Notably, 25.7% of the children manifested a combination of multiple metabolic disorders. Significant variations in the prevalence of hyperuricosuria were observed across different age groups. Boys exhibited higher incidences of hypercalcemia and metabolic abnormalities compared to girls, though no statistically significant differences were noted in other disorders. Conclusion: In summary, our findings indicate the presence of abnormal urinary metabolic risk factors in over half of children diagnosed with kidney stones. Hypercalciuria was the more frequent risk factor following hyperuricosuria and hyperoxaluria, cystinuria with prevalence of 30.2%, 22.6%, 20.6%, and (2.1%) respectively.
- Open Access
- 7 July 2024
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 34 (4)
Acute Renal Failure in the Pediatric Intensive Care Unit: Incidence and Its Effects on Clinical Outcomes
Background: Renal dysfunction is a prevalent complication among patients admitted to intensive care units (ICUs), significantly impacting patient outcomes. Objectives: This study focuses on assessing the incidence of acute renal failure (ARF) in pediatric patients hospitalized in ICUs, exploring its occurrence and associated effects on patient outcomes. Methods: A prospective observational study was conducted to examine the incidence of ARF in pediatric patients admitted to a tertiary pediatric hospital's intensive care unit (PICU) in Iran from September 2019 to August 2020. Patients who developed ARF during their ICU stay were included in the study. Clinical and laboratory data were systematically collected upon admission and on a daily basis thereafter. This data collection aimed to elucidate differences in etiology, disease severity, and clinical practices, and to ascertain their impact on patient outcomes. Results: Out of 1145 pediatric ICU admissions, 4.3% experienced acute renal failure during their hospitalization. Of the 49 affected patients, information was available for 46 individuals, constituting the final analysis cohort. The staging of renal failure was categorized as follows: Stage I (45.7%), Stage II (19.6%), and Stage III (34.8%). Acute tubular necrosis emerged as the predominant cause of acute kidney injury (60.8%). The mortality rate among these patients was notably high at 39.1%, compared to the general PICU mortality rate of 7.1% during the study period. Non-survivors exhibited a higher prevalence of antibiotic use, particularly aminoglycosides and antifungal drugs. Additionally, resuscitation procedures were more frequently documented among non-survivors. Conclusions: Approximately 4.3% of pediatric ICU patients develop acute renal failure, with half of the cases manifesting within the initial 24 hours of hospitalization. Acute tubular necrosis stands out as the primary cause of acute kidney injury. A substantial proportion of patients (39.1%) succumb to the condition, particularly those subjected to resuscitation efforts or prescribed multiple antibiotics and antifungal drugs during hospitalization.
- 7 July 2024
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 34 (4)
Open AccessAcute Renal Failure in the Pediatric Intensive Care Unit: Incidence and Its Effects on Clinical Outcomes
Background: Renal dysfunction is a prevalent complication among patients admitted to intensive care units (ICUs), significantly impacting patient outcomes. Objectives: This study focuses on assessing the incidence of acute renal failure (ARF) in pediatric patients hospitalized in ICUs, exploring its occurrence and associated effects on patient outcomes. Methods: A prospective observational study was conducted to examine the incidence of ARF in pediatric patients admitted to a tertiary pediatric hospital's intensive care unit (PICU) in Iran from September 2019 to August 2020. Patients who developed ARF during their ICU stay were included in the study. Clinical and laboratory data were systematically collected upon admission and on a daily basis thereafter. This data collection aimed to elucidate differences in etiology, disease severity, and clinical practices, and to ascertain their impact on patient outcomes. Results: Out of 1145 pediatric ICU admissions, 4.3% experienced acute renal failure during their hospitalization. Of the 49 affected patients, information was available for 46 individuals, constituting the final analysis cohort. The staging of renal failure was categorized as follows: Stage I (45.7%), Stage II (19.6%), and Stage III (34.8%). Acute tubular necrosis emerged as the predominant cause of acute kidney injury (60.8%). The mortality rate among these patients was notably high at 39.1%, compared to the general PICU mortality rate of 7.1% during the study period. Non-survivors exhibited a higher prevalence of antibiotic use, particularly aminoglycosides and antifungal drugs. Additionally, resuscitation procedures were more frequently documented among non-survivors. Conclusions: Approximately 4.3% of pediatric ICU patients develop acute renal failure, with half of the cases manifesting within the initial 24 hours of hospitalization. Acute tubular necrosis stands out as the primary cause of acute kidney injury. A substantial proportion of patients (39.1%) succumb to the condition, particularly those subjected to resuscitation efforts or prescribed multiple antibiotics and antifungal drugs during hospitalization.
- Open Access
- 1 January 2024
- Published by Wiley in Occupational Therapy International
- Vol. 2024 (1) , 9994862
A Delphi Exploration of Toileting Activity Performance in Individuals With Cerebral Palsy Within the ICF‐CY Framework: Unveiling Influential Factors
Introduction: Cerebral palsy (CP) is a common motor and postural developmental disability impacting daily activities like toileting. Despite its importance, toileting has often been undervalued in healthcare. This study is aimed at identifying and assessing the level of influence of various factors affecting toileting in individuals with CP using the International Classification of Functioning, Disability and Health for Children and Youth (ICF‐CY) framework.Methods: The Delphi method was employed to reach a consensus on factors influencing toileting in individuals with CP. One hundred fifty‐eight professionals from 17 countries, each with at least 3 years’ experience in CP and/or toileting, participated in this two‐round study. Ethical approval (IR.IUMS.REC.1400.1111) and informed consent were obtained. The questionnaire, available in Farsi and English, used a Likert scale (5 = very high impact to 1 = no impact). Factors with 75% agreement and a mean above 3.75 were included in the final list, while those with 50%–75% agreement or a mean between 2.5 and 3.75 proceeded to the second round. Factors were initially identified through a literature review and research team consultation and categorized according to the ICF‐CY framework using the ICF 10 RULES. Validation and refinement were done through focus groups with caregivers and experienced professionals to ensure alignment with the framework and methodological rigor.Results: The study highlighted significant factors influencing toileting activities in individuals with CP. Within the ICF‐CY framework, “neuromusculoskeletal and movement‐related functions” scored highest at 94.5% in “body functions and structures.” “Toilet environment” scored 90.5% in “environmental factors.” Support and relationship factors scored 82.3%. Attitudes toward “menstruation” ranked highest at 92.9%. Associated deficits with CP ranked top in personal factors at 93.7%.Conclusion: The study identifies key factors influencing toileting activity performance in individuals with CP. “Main caregiver” emerges as a pivotal factor, followed by neuromusculoskeletal functions, personal factors, attitudes toward menstruation, the toilet environment, and support and relationships.
- 1 January 2024
- Published by Wiley in Occupational Therapy International
- Vol. 2024 (1) , 9994862
Open AccessA Delphi Exploration of Toileting Activity Performance in Individuals With Cerebral Palsy Within the ICF‐CY Framework: Unveiling Influential Factors
Introduction: Cerebral palsy (CP) is a common motor and postural developmental disability impacting daily activities like toileting. Despite its importance, toileting has often been undervalued in healthcare. This study is aimed at identifying and assessing the level of influence of various factors affecting toileting in individuals with CP using the International Classification of Functioning, Disability and Health for Children and Youth (ICF‐CY) framework.Methods: The Delphi method was employed to reach a consensus on factors influencing toileting in individuals with CP. One hundred fifty‐eight professionals from 17 countries, each with at least 3 years’ experience in CP and/or toileting, participated in this two‐round study. Ethical approval (IR.IUMS.REC.1400.1111) and informed consent were obtained. The questionnaire, available in Farsi and English, used a Likert scale (5 = very high impact to 1 = no impact). Factors with 75% agreement and a mean above 3.75 were included in the final list, while those with 50%–75% agreement or a mean between 2.5 and 3.75 proceeded to the second round. Factors were initially identified through a literature review and research team consultation and categorized according to the ICF‐CY framework using the ICF 10 RULES. Validation and refinement were done through focus groups with caregivers and experienced professionals to ensure alignment with the framework and methodological rigor.Results: The study highlighted significant factors influencing toileting activities in individuals with CP. Within the ICF‐CY framework, “neuromusculoskeletal and movement‐related functions” scored highest at 94.5% in “body functions and structures.” “Toilet environment” scored 90.5% in “environmental factors.” Support and relationship factors scored 82.3%. Attitudes toward “menstruation” ranked highest at 92.9%. Associated deficits with CP ranked top in personal factors at 93.7%.Conclusion: The study identifies key factors influencing toileting activity performance in individuals with CP. “Main caregiver” emerges as a pivotal factor, followed by neuromusculoskeletal functions, personal factors, attitudes toward menstruation, the toilet environment, and support and relationships.
- Open Access
- 16 December 2023
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 34 (1)
Microalbuminuria in Children with Type 1 Diabetes and Its Relationship with Body Mass Index, Hemoglobin A1c, and Age at Diabetes Onset
Background: Children with type 1 diabetes are at risk of developing microvascular and macrovascular complications, with diabetic nephropathy (DN) being a significant microvascular complication. Microalbuminuria is a crucial diagnostic marker for the early detection of DN and can predict the risk of vascular complications. Objectives: This study aimed to investigate the relationship between microalbuminuria and body mass index (BMI), changes in hemoglobin A1c (HbA1c), and the age of disease onset in children and adolescents with type 1 diabetes. Methods: This cross-sectional study was conducted in Mofid and Imam Hossein hospitals in Tehran, Iran, within 2021 - 2022. This study included 120 children and adolescents aged 5 - 20 years who had been diagnosed with type 1 diabetes for at least 3 years. All patients underwent evaluation for microalbuminuria, and its association with BMI, HbA1c levels, and the age of diabetes onset was assessed. Results: Among the 120 patients, 51% were female. Microalbuminuria was present in 15% of patients; however, 13.3% were overweight or obese. Furthermore, 91% of patients had HbA1c levels above 7%. The mean age of diabetes onset was 13 years, and the mean disease duration was 5.5 years. The study revealed a significant association between microalbuminuria and HbA1c levels, BMI, and the age of diabetes onset (P-values < 0.05). Conclusions: Microalbuminuria showed a positive correlation with increased BMI and poorer glycemic control. An early age of diabetes onset was identified as a risk factor for microalbuminuria in children and adolescents with diabetes.
- 16 December 2023
- Published by Brieflands in Iranian Journal of Pediatrics
- Vol. 34 (1)
Open AccessMicroalbuminuria in Children with Type 1 Diabetes and Its Relationship with Body Mass Index, Hemoglobin A1c, and Age at Diabetes Onset
Background: Children with type 1 diabetes are at risk of developing microvascular and macrovascular complications, with diabetic nephropathy (DN) being a significant microvascular complication. Microalbuminuria is a crucial diagnostic marker for the early detection of DN and can predict the risk of vascular complications. Objectives: This study aimed to investigate the relationship between microalbuminuria and body mass index (BMI), changes in hemoglobin A1c (HbA1c), and the age of disease onset in children and adolescents with type 1 diabetes. Methods: This cross-sectional study was conducted in Mofid and Imam Hossein hospitals in Tehran, Iran, within 2021 - 2022. This study included 120 children and adolescents aged 5 - 20 years who had been diagnosed with type 1 diabetes for at least 3 years. All patients underwent evaluation for microalbuminuria, and its association with BMI, HbA1c levels, and the age of diabetes onset was assessed. Results: Among the 120 patients, 51% were female. Microalbuminuria was present in 15% of patients; however, 13.3% were overweight or obese. Furthermore, 91% of patients had HbA1c levels above 7%. The mean age of diabetes onset was 13 years, and the mean disease duration was 5.5 years. The study revealed a significant association between microalbuminuria and HbA1c levels, BMI, and the age of diabetes onset (P-values < 0.05). Conclusions: Microalbuminuria showed a positive correlation with increased BMI and poorer glycemic control. An early age of diabetes onset was identified as a risk factor for microalbuminuria in children and adolescents with diabetes.
- Open Access
- 4 July 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
End stage renal disease due to primary hyperoxaluria in a 7-month infant; a case report
Primary hyperoxaluria (PH) is a rare genetic metabolic disease presented severely in infants with end-stage renal disease (ESRD). Promoting diagnosis with aggressive management is essential in these patients. Here we presented a rare case of primary hyperoxaluria type 1 (PH1) in a seven-month infant girl who underwent dialysis with prospective kidney transplantation in the future.
- 4 July 2023
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
Open AccessEnd stage renal disease due to primary hyperoxaluria in a 7-month infant; a case report
Primary hyperoxaluria (PH) is a rare genetic metabolic disease presented severely in infants with end-stage renal disease (ESRD). Promoting diagnosis with aggressive management is essential in these patients. Here we presented a rare case of primary hyperoxaluria type 1 (PH1) in a seven-month infant girl who underwent dialysis with prospective kidney transplantation in the future.
- 12 November 2022
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 19 (5) , 425-437
Sphingosine phosphate lyase insufficiency syndrome: a systematic review
Background Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused by biallelic mutations in SGPL1. Here, we conducted a systematic review to delineate the characteristics of SPLIS patients. Methods A literature search was performed in PubMed, Web of Science, and Scopus databases, and eligible studies were included. For all patients, demographic, clinical, laboratory, and molecular data were collected and analyzed. Results Fifty-five SPLIS patients (54.9% male, 45.1% female) were identified in 19 articles. Parental consanguinity and positive family history were reported in 70.9% and 52.7% of patients, respectively. Most patients (54.9%) primarily manifested within the first year of life, nearly half of whom survived, while all patients with a prenatal diagnosis of SPLIS (27.5%) died at a median [interquartile (IQR)] age of 2 (1.4–5.3) months (P = 0.003). The most prevalent clinical feature was endocrinopathies, including primary adrenal insufficiency (PAI) (71.2%) and hypothyroidism (32.7%). Kidney disorders (42, 80.8%) were mainly in the form of steroid-resistant nephrotic syndrome (SRNS) and progressed to end-stage kidney disease (ESKD) in 19 (36.5%) patients at a median (IQR) age of 6 (1.4–42.6) months. Among 30 different mutations in SGPL1, the most common was c.665G > A (p.Arg222Gln) in 11 (20%) patients. Twenty-six (49.1%) patients with available outcome were deceased at a median (IQR) age of 5 (1.5–30.5) months, mostly following ESKD (23%) or sepsis/septic shock (23%). Conclusion In patients with PAI and/or SRNS, SGPL1 should be added to diagnostic genetic panels, which can provide an earlier diagnosis of SPLIS and prevention of ESKD and other life-threatening complications.
- 12 November 2022
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 19 (5) , 425-437
Sphingosine phosphate lyase insufficiency syndrome: a systematic review
Background Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused by biallelic mutations in SGPL1. Here, we conducted a systematic review to delineate the characteristics of SPLIS patients. Methods A literature search was performed in PubMed, Web of Science, and Scopus databases, and eligible studies were included. For all patients, demographic, clinical, laboratory, and molecular data were collected and analyzed. Results Fifty-five SPLIS patients (54.9% male, 45.1% female) were identified in 19 articles. Parental consanguinity and positive family history were reported in 70.9% and 52.7% of patients, respectively. Most patients (54.9%) primarily manifested within the first year of life, nearly half of whom survived, while all patients with a prenatal diagnosis of SPLIS (27.5%) died at a median [interquartile (IQR)] age of 2 (1.4–5.3) months (P = 0.003). The most prevalent clinical feature was endocrinopathies, including primary adrenal insufficiency (PAI) (71.2%) and hypothyroidism (32.7%). Kidney disorders (42, 80.8%) were mainly in the form of steroid-resistant nephrotic syndrome (SRNS) and progressed to end-stage kidney disease (ESKD) in 19 (36.5%) patients at a median (IQR) age of 6 (1.4–42.6) months. Among 30 different mutations in SGPL1, the most common was c.665G > A (p.Arg222Gln) in 11 (20%) patients. Twenty-six (49.1%) patients with available outcome were deceased at a median (IQR) age of 5 (1.5–30.5) months, mostly following ESKD (23%) or sepsis/septic shock (23%). Conclusion In patients with PAI and/or SRNS, SGPL1 should be added to diagnostic genetic panels, which can provide an earlier diagnosis of SPLIS and prevention of ESKD and other life-threatening complications.